% | $
Quotes you view appear here for quick access.

Lpath Inc. Message Board

  • john_j_315 john_j_315 Jun 19, 2014 1:35 PM Flag

    How it's done:

    " OPKO Health, Inc. (OPK), a multinational biopharmaceutical and diagnostics company that is developing a novel long-acting human growth hormone product (hGH-CTP) for the treatment of growth hormone deficiency (GHD), today announced it will hold a conference call and webcast on Tuesday, June 24, 2014 at 8:30 a.m. EDT (7:30 a.m. CDT).

    During the call, OPKO Biologics management will discuss data from the company's advanced phase 2 trial of hGH-CTP in growth hormone deficient pediatric subjects. The pharmacokinetic and pharmacodynamics portion of the results will also be presented at a poster presentation on the prior Monday afternoon from 2:00 p.m. to 4:00 p.m. EDT (1:00 p.m. to 3:00 p.m. CDT) during the International Congress of Endocrinology and Endocrine Society's Annual Meeting and Expo at the McCormick Place West in Chicago, IL."

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.254+0.018(+7.63%)Nov 27 12:57 PMEST